Literature DB >> 6194117

Isolation and characterization of a monoclonal antibody directed against type 1 fimbriae organelles from Escherichia coli.

B I Eisenstein, J R Clements, D C Dodd.   

Abstract

We have isolated a mouse immunoglobulin M (IgM) monoclonal antibody directed against type 1 fimbriae from the Escherichia coli K-12-derived strain CSH50. Antibody specificity was demonstrated by (i) the ability of fimbriate but not nonfimbriate bacteria to compete with solid-phase purified fimbriae for antibody binding in an enzyme-linked immunosorbent assay, (ii) the visualized binding of antibody to fimbriae alone by electron microscopy, and (iii) the appearance in a radioimmunoprecipitation assay of a single electrophoretic band comigrating with pure type 1 fimbriae. The monoclonal antibody was further characterized by immunoblot analysis and compared with previously prepared rabbit anti-fimbrial antisera. Whereas the monospecific but polyvalent antisera recognized both fimbrial monomeric subunits and non-disaggregated fimbriae organelles, the monoclonal antibody recognized only the intact organelles even when the samples were prepared under nondenaturing conditions. The monoclonal antibody, therefore, might be directed against an epitope spanning two (or more) adjacent fimbrial subunits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194117      PMCID: PMC264562          DOI: 10.1128/iai.42.1.333-340.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Structure of common pili from Escherichia coli.

Authors:  J C McMichael; J T Ou
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

2.  Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control.

Authors:  B I Eisenstein
Journal:  Science       Date:  1981-10-16       Impact factor: 47.728

3.  Loss of lectin-like activity in aberrant type 1 fimbriae of Escherichia coli.

Authors:  B I Eisenstein; I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer-membrane proteins?

Authors:  K Ito; P J Bassford; J Beckwith
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

5.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

6.  Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

Authors:  F T Liu; J W Bohn; E L Ferry; H Yamamoto; C A Molinaro; L A Sherman; N R Klinman; D H Katz
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

9.  Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin.

Authors:  B I Eisenstein; I Ofek; E H Beachey
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

10.  A clonal analysis of the IgE response and its implications with regard to isotope commitment.

Authors:  J M Teale; F T Liu; D H Katz
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  13 in total

1.  Type 1 fimbriation and fimE mutants of Escherichia coli K-12.

Authors:  I C Blomfield; M S McClain; J A Princ; P J Calie; B I Eisenstein
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

2.  Kinetic analysis of the synthesis and assembly of type 1 fimbriae of Escherichia coli.

Authors:  D C Dodd; B I Eisenstein
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

3.  Dependence of secretion and assembly of type 1 fimbrial subunits of Escherichia coli on normal protein export.

Authors:  D C Dodd; P J Bassford; B I Eisenstein
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

4.  Immunoelectron microscopic analysis of elongation of type 1 fimbriae in Escherichia coli.

Authors:  M A Lowe; S C Holt; B I Eisenstein
Journal:  J Bacteriol       Date:  1987-01       Impact factor: 3.490

5.  An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli.

Authors:  J M Abraham; C S Freitag; J R Clements; B I Eisenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

6.  Inversion-independent phase variation of type 1 fimbriae in Escherichia coli.

Authors:  M S McClain; I C Blomfield; K J Eberhardt; B I Eisenstein
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

7.  Utilization of anion-exchange chromatography and monoclonal antibodies to characterize multiple pilus types on a uropathogenic Escherichia coli O6 isolate.

Authors:  R M Gander; V L Thomas
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Characterization of monoclonal antibodies specific for adhesion: isolation of an adhesin of Streptococcus sanguis FW213.

Authors:  B L Elder; P Fives-Taylor
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Genetic analysis of the phase variation control of expression of type 1 fimbriae in Escherichia coli.

Authors:  C S Freitag; J M Abraham; J R Clements; B I Eisenstein
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

10.  Purification and characterization of a pilin specific for Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius (H. aegyptius) strains.

Authors:  R S Weyant; W F Bibb; D S Stephens; B P Holloway; W F Moo-Penn; K A Birkness; L O Helsel; L W Mayer
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.